![Sean Tucker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Tucker
Oprichter bij
VAXART, INC.
Vermogen: 189 381 $ op 31-08-2026
Profiel
Sean Tucker is the founder of Vaxart, Inc., founded in 2004.
Titles held at Vaxart, Inc. included Director & Vice President-Research from 2012 to 2013, and Chief Scientific Officer & Senior Vice President.
Former jobs include Principal at The Dow Chemical Co., Principal at Systemix, Inc., and Principal at Genteric, Inc. Education history includes undergraduate and doctorate degrees from the University of Washington, and a graduate degree from the University of California, Berkeley.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VAXART, INC. 0,15% | 26-05-2026 | 371.336 ( 0,15% ) | 189 381 $ | 31-08-2026 |
Actieve functies van Sean Tucker
| Bedrijven | Functie | Begin |
|---|---|---|
| VAXART, INC. | Oprichter | 01-03-2004 |
Eerdere bekende functies van Sean Tucker
| Bedrijven | Functie | Einde |
|---|---|---|
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - |
Genteric, Inc.
 Genteric, Inc. Pharmaceuticals: MajorHealth Technology Develops revolutionary therapeutic protein delivery technology | Corporate Officer/Principal | - |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Corporate Officer/Principal | - |
Vaxart, Inc. /Old/
 Vaxart, Inc. /Old/ BiotechnologyHealth Technology Develops technology for oral vaccination against infectious agents | Oprichter | - |
Opleiding van Sean Tucker
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
36
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
The Dow Chemical Co.
 The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
Vaxart, Inc. /Old/
Vaxart, Inc. /Old/ BiotechnologyHealth Technology Develops technology for oral vaccination against infectious agents | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genteric, Inc.
Genteric, Inc. Pharmaceuticals: MajorHealth Technology Develops revolutionary therapeutic protein delivery technology | Health Technology |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
